Daniele Cardoso
Profile
Daniele Cardoso was the President & CEO of Infa Group SpA, a Director at InVasc Therapeutics, Inc., and a Principal at Laboratorio Chimico Internazionale SpA.
Former positions of Daniele Cardoso
| Companies | Position | End |
|---|---|---|
InVasc Therapeutics, Inc.
 InVasc Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology InVasc Therapeutics, Inc. engages in the development of drugs for treating and preventing cardio metabolic disease. It specializes in target-specific drug discovery with several potential drug therapies at the pre-clinical stage. The company was founded in 2006 and is headquartered in Tucker, GA. | Director/Board Member | - |
Laboratorio Chimico Internazionale SpA
 Laboratorio Chimico Internazionale SpA Pharmaceuticals: MajorHealth Technology Laboratorio Chimico Internazionale SpA manufactures and supplies active pharmaceutical ingredients in Italy. Its products include acamprosate calcium, alfa-lipoic acids, alfa-lipoic acid carnitine salts, alfa-lipoic acid lysine salts, allopurinol, amiodarone hydrochloride, atovaquone, bezafibrate, butamirate citrate, carisoprodol and diacerein. The company was founded by Ruggero Cardoso in 1966 and is headquartered in Milan, Italy. | Corporate Officer/Principal | - |
Infa Group SpA
 Infa Group SpA Chemicals: Major DiversifiedProcess Industries Infa Group SpA distributes and sources active pharmaceutical ingredients. Its products and services include custom synthesis, generic APIs, Acamprosate calcium, Agomelatine, Ambrisentan, Ambroxol, Ambroxol Theophyllinate, Amiloride, Amiodarone, Amisulpride, Amitriptyline, Amorolfine and Atovaquone. The company was founded by Ruggero Cardoso in 1953 and is headquartered in Milan, Italy. | Chief Executive Officer | - |
Experiences
Positions held
Linked companies
| Private companies | 3 |
|---|---|
Infa Group SpA
Infa Group SpA Chemicals: Major DiversifiedProcess Industries Infa Group SpA distributes and sources active pharmaceutical ingredients. Its products and services include custom synthesis, generic APIs, Acamprosate calcium, Agomelatine, Ambrisentan, Ambroxol, Ambroxol Theophyllinate, Amiloride, Amiodarone, Amisulpride, Amitriptyline, Amorolfine and Atovaquone. The company was founded by Ruggero Cardoso in 1953 and is headquartered in Milan, Italy. | Process Industries |
InVasc Therapeutics, Inc.
InVasc Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology InVasc Therapeutics, Inc. engages in the development of drugs for treating and preventing cardio metabolic disease. It specializes in target-specific drug discovery with several potential drug therapies at the pre-clinical stage. The company was founded in 2006 and is headquartered in Tucker, GA. | Health Technology |
Laboratorio Chimico Internazionale SpA
Laboratorio Chimico Internazionale SpA Pharmaceuticals: MajorHealth Technology Laboratorio Chimico Internazionale SpA manufactures and supplies active pharmaceutical ingredients in Italy. Its products include acamprosate calcium, alfa-lipoic acids, alfa-lipoic acid carnitine salts, alfa-lipoic acid lysine salts, allopurinol, amiodarone hydrochloride, atovaquone, bezafibrate, butamirate citrate, carisoprodol and diacerein. The company was founded by Ruggero Cardoso in 1966 and is headquartered in Milan, Italy. | Health Technology |
- Stock Market
- Insiders
- Daniele Cardoso
